Dawnrays Pharmaceutical (Holdings) Limited (2348.HK)

HKD 1.16

(0.87%)

Operating Expenses Summary of Dawnrays Pharmaceutical (Holdings) Limited

  • Dawnrays Pharmaceutical (Holdings) Limited's latest annual operating expenses in 2023 was 210.13 Million CNY , down -39.57% from previous year.
  • Dawnrays Pharmaceutical (Holdings) Limited's latest quarterly operating expenses in 2023 FY was 210.13 Million CNY , down -39.57% from previous quarter.
  • Dawnrays Pharmaceutical (Holdings) Limited reported a annual operating expenses of 347.75 Million CNY in annual operating expenses 2022, up 36.04% from previous year.
  • Dawnrays Pharmaceutical (Holdings) Limited reported a annual operating expenses of 255.62 Million CNY in annual operating expenses 2021, up 12.67% from previous year.
  • Dawnrays Pharmaceutical (Holdings) Limited reported a quarterly operating expenses of 38.96 Million CNY for 2023 Q2, down 0.0% from previous quarter.
  • Dawnrays Pharmaceutical (Holdings) Limited reported a quarterly operating expenses of 201.01 Million CNY for 2023 Q4, down 0.0% from previous quarter.

Annual Operating Expenses Chart of Dawnrays Pharmaceutical (Holdings) Limited (2023 - 2002)

Historical Annual Operating Expenses of Dawnrays Pharmaceutical (Holdings) Limited (2023 - 2002)

Year Operating Expenses Operating Expenses Growth
2023 210.13 Million CNY -39.57%
2022 347.75 Million CNY 36.04%
2021 255.62 Million CNY 12.67%
2020 226.88 Million CNY 2.72%
2019 220.87 Million CNY -11.22%
2018 248.8 Million CNY 14.41%
2017 217.46 Million CNY 13.51%
2016 191.57 Million CNY -9.94%
2015 212.72 Million CNY 0.16%
2014 212.38 Million CNY -3.47%
2013 220.02 Million CNY 44.76%
2012 151.99 Million CNY -19.11%
2011 187.9 Million CNY 12.7%
2010 166.72 Million CNY -5.7%
2009 176.8 Million CNY 25.75%
2008 140.6 Million CNY 6.29%
2007 132.28 Million CNY 13.39%
2006 116.65 Million CNY 5.06%
2005 111.04 Million CNY 2.61%
2004 108.22 Million CNY 15.87%
2003 93.4 Million CNY 30.24%
2002 71.71 Million CNY 0.0%

Peer Operating Expenses Comparison of Dawnrays Pharmaceutical (Holdings) Limited

Name Operating Expenses Operating Expenses Difference
Pak Fah Yeow International Limited 24.42 Million HKD -760.367%
Grand Pharmaceutical Group Limited 3.86 Billion HKD 94.557%
Extrawell Pharmaceutical Holdings Limited 35.52 Million HKD -491.483%
Wai Yuen Tong Medicine Holdings Limited 353.93 Million HKD 40.628%
Qianhai Health Holdings Limited 17.1 Million HKD -1128.722%
Lee's Pharmaceutical Holdings Limited 590.99 Million HKD 64.444%
Essex Bio-Technology Limited 1.22 Billion HKD 82.901%
Tongfang Kontafarma Holdings Limited 503.46 Million HKD 58.262%
PuraPharm Corporation Limited 216.62 Million HKD 2.997%
SSY Group Limited 1.98 Billion HKD 89.391%
JBM (Healthcare) Limited 163.87 Million HKD -28.229%
Jacobson Pharma Corporation Limited 287.34 Million HKD 26.871%
China Resources Pharmaceutical Group Limited 29.35 Billion HKD 99.284%